Michael P. Cooke, Chief Scientific Officer at Magenta Therapeutics, Inc. (MGTA), sold 7,500 shares at $13.90 ($104K) on 2019-06-17, disclosed to the SEC on 2019-06-18.
Open-market sale of $104k MGTA by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MGTA | SELL | 2019-11-01 | $53K | — | Filing → |
| MGTA | SELL | 2019-10-03 | $50K | — | Filing → |
| MGTA | SELL | 2019-09-19 | $20K | — | Filing → |